<DOC>
	<DOCNO>NCT00005668</DOCNO>
	<brief_summary>To compare safety effectiveness itraconazole oral solution placebo treatment pulmonary aspergilloma . Aspergilloma `` fungal ball '' lung cause Aspergillus . The infection spread lung blood organ . Aspergilloma life-threatening ; therefore , effective treatment need .</brief_summary>
	<brief_title>A Multicenter , Prospective , Randomized , Double-Blind Clinical Trial Comparing Itraconazole Oral Solution Cyclodextrin Placebo Treatment Aspergilloma</brief_title>
	<detailed_description>Patients randomly select receive itraconazole oral solution mouth inactive placebo ( oral cyclodextrin solution ) twice daily 12 month .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Aspergillosis</mesh_term>
	<mesh_term>Lung Diseases , Fungal</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Itraconazole</mesh_term>
	<mesh_term>Hydroxyitraconazole</mesh_term>
	<criteria>You may eligible study : Are 18 year age old . Have diagnose aspergilloma within last month . Have ( history ) least one following : 1. positive test Aspergillus specie . 2. presence antibody Aspergillus . Are willing participate study 2 full year . Are female pregnant . Are breastfeed . Agree use barrier method birth control / contraception study 30 day . You eligible study : Have history allergy triazole imidazole drug . Are unable take oral medication . Are expected live month . Have lung biopsy indicate Aspergillus infection . Have radiation therapy within last 6 month . Require treatment certain medication . Received amphotericin , amphotericin lipid formulation , fluconazole , itraconazole two week prior study entry . Received chemotherapy within last 6 month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2005</verification_date>
</DOC>